American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68 | 34 | 10 | 2 | 17 |
| Receivables | 591 | 284 | 39 | 285 | 538 |
| Inventories | 0 | 379 | 380 | 401 | 419 |
| Other current assets | 0 | 0 | 217 | 21 | 29 |
| TOTAL | $659 | $769 | $670 | $742 | $1,038 |
| Non-Current Assets | |||||
| PPE Net | 0 | 466 | 479 | 491 | 504 |
| Other Non-Current Assets | 0 | 34 | 28 | 23 | 23 |
| TOTAL | $N/A | $500 | $507 | $514 | $527 |
| Total Assets | $659 | $1,269 | $1,177 | $1,256 | $1,565 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 175 | 2,230 | 1,595 | 1,465 | 125 |
| Accounts payable and accrued liabilities | 572 | 760 | 950 | 885 | 843 |
| Accrued Expenses | 370 | 608 | 634 | 547 | 543 |
| TOTAL | $1,117 | $3,602 | $3,192 | $2,962 | $2,871 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 6 | 7 | 2 | 2 |
| TOTAL | $N/A | $6 | $7 | $2 | $2 |
| Total Liabilities | $1,117 | $3,608 | $3,199 | $2,964 | $2,873 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,098 | 48,098 | 48,098 | 48,098 | 48,098 |
| Common Shares | 481 | 481 | 481 | 481 | 481 |
| Retained earnings | -23,342 | -25,223 | -24,906 | -24,592 | -24,192 |
| TOTAL | $-458 | $-2,339 | $-2,022 | $-1,708 | $-1,308 |
| Total Liabilities And Equity | $659 | $1,269 | $1,177 | $1,256 | $1,565 |